Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/179953
Title: Family History and Gastric Cancer Risk: A Pooled Investigation in the Stomach Cancer Pooling (STOP) Project Consortium
Author: Vitelli Storelli, Facundo
Rubín García, María
Pelucchi, Claudio
Benavente, Yolanda
Bonzi, Rossella
Rota, Matteo
Palli, Domenico
Ferraroni, Monica
Lunet, Nuno
Morais, Samantha
Ye, Weimin
Plymoth, Amelie
Malekzadeh, Reza
Tsugane, Shoichiro
Hidaka, Akihisa
Aragonès Sanz, Núria
Castaño-Vinyals, Gemma
Zaridze, David
Maximovich, Dmitry
Vioque, Jesús
García de la Hera, Manuela
Zhang, Zuo-feng
Shigueaki Hamada, Gerson
Pakseresht, Mohammadreza
Pourfarzi, Farhad
Mu, Lina
Boccia, Stefania
Pastorino, Roberta
Yu, Guo-Pei
Lagiou, Areti
Lagiou, Pagona
Negri, Eva
La Vecchia, Carlo
Martín Sánchez, Vicente
Keywords: Càncer d'estómac
Històries clíniques
Stomach cancer
Medical records
Issue Date: 30-Jul-2021
Publisher: MDPI AG
Abstract: Although there is a clear relationship between family history (FH) and the risk of gastric cancer (GC), quantification is still needed in relation to different histological types and anatomical sites, and in strata of covariates. The objective was to analyze the risk of GC according to first-degree FH in a uniquely large epidemiological consortium of GC. This investigation includes 5946 cases and 12,776 controls from 17 studies of the Stomach Cancer Pooling (StoP) Project consortium. Summary odds ratios (OR) and the corresponding 95% confidence intervals (CIs) were calculated by pooling study-specific ORs using fixed-effect model meta-analysis techniques. Stratified analyses were carried out by sex, age, tumor location and histological type, smoking habit, socioeconomic status, alcohol intake and fruit consumption. The pooled OR for GC was 1.84 (95% CI: 1.64-2.04; I2 = 6.1%, P heterogeneity = 0.383) in subjects with vs. those without first-degree relatives with GC. No significant differences were observed among subgroups of sex, age, geographic area or study period. Associations tended to be stronger for non-cardia (OR = 1.82; 95% CI: 1.59-2.05 for subjects with FH) than for cardia GC (OR = 1.38; 95% CI: 0.98-1.77), and for the intestinal (OR = 1.92; 95% CI: 1.62-2.23) than for the diffuse histotype (OR = 1.62; 95% CI: 1.28-1.96). This analysis confirms the effect of FH on the risk of GC, reporting an approximately doubled risk, and provides further quantification of the risk of GC according to the subsite and histotype. Considering these findings, accounting for the presence of FH to carry out correct prevention and diagnosis measures is of the utmost importance.
Note: Reproducció del document publicat a: https://doi.org/10.3390/cancers13153844
It is part of: Cancers, 2021, vol. 13, num. 15, p. 3844
URI: http://hdl.handle.net/2445/179953
Related resource: https://doi.org/10.3390/cancers13153844
ISSN: 2072-6694
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
cancers-13-03844.pdf1.9 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons